135 related articles for article (PubMed ID: 34924212)
1. Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation.
Mallik S; Yeung D; Rehn J; Nguyen T; Dunlop L; Kwan J; White D
Pathology; 2022 Aug; 54(5):631-634. PubMed ID: 34924212
[No Abstract] [Full Text] [Related]
2. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
[TBL] [Abstract][Full Text] [Related]
3. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
Novakova M; Zaliova M; Fiser K; Vakrmanova B; Slamova L; Musilova A; Brüggemann M; Ritgen M; Fronkova E; Kalina T; Stary J; Winkowska L; Svec P; Kolenova A; Stuchly J; Zuna J; Trka J; Hrusak O; Mejstrikova E
Haematologica; 2021 Aug; 106(8):2066-2075. PubMed ID: 32646889
[TBL] [Abstract][Full Text] [Related]
4. A PAX5 P80R pediatric B acute lymphoblastic leukemia with monocytic lineage switch at diagnosis: Deciphering classification ambiguity.
Strullu M; Caye-Eude A; Fenneteau O; Arfeuille C; Cuccuini W; Cavé H; Baruchel A; Lainey E
Pediatr Blood Cancer; 2024 Mar; 71(3):e30842. PubMed ID: 38189777
[No Abstract] [Full Text] [Related]
5. PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis.
Kroeze LI; Scheijen B; Hebeda KM; Rijntjes J; Luijks JACW; Evers D; Hobo W; Groenen PJTA; van den Brand M
Virchows Arch; 2023 Jul; 483(1):105-110. PubMed ID: 36241730
[TBL] [Abstract][Full Text] [Related]
6. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
[TBL] [Abstract][Full Text] [Related]
7.
Passet M; Boissel N; Sigaux F; Saillard C; Bargetzi M; Ba I; Thomas X; Graux C; Chalandon Y; Leguay T; Lengliné E; Konopacki J; Quentin S; Delabesse E; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Lhéritier V; Soulier J; Dombret H; Clappier E;
Blood; 2019 Jan; 133(3):280-284. PubMed ID: 30510083
[No Abstract] [Full Text] [Related]
8. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
9. Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia.
Santoro A; Bica MG; Dagnino L; Agueli C; Salemi D; Cannella S; Veltroni M; Cetica V; Giarin E; Fabbiano F; Basso G; Arico M
Br J Haematol; 2009 Sep; 146(6):686-9. PubMed ID: 19604238
[No Abstract] [Full Text] [Related]
10. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
11. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
Fouad FM; Eid JI
Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
[TBL] [Abstract][Full Text] [Related]
12. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
[TBL] [Abstract][Full Text] [Related]
13. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
[TBL] [Abstract][Full Text] [Related]
14. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
15. Genomics: global views of leukaemia.
Golub TR
Nature; 2007 Apr; 446(7137):739-40. PubMed ID: 17429386
[No Abstract] [Full Text] [Related]
16. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
[TBL] [Abstract][Full Text] [Related]
17. Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
Nebral K; König M; Harder L; Siebert R; Haas OA; Strehl S
Br J Haematol; 2007 Oct; 139(2):269-74. PubMed ID: 17897302
[TBL] [Abstract][Full Text] [Related]
18. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
[TBL] [Abstract][Full Text] [Related]
19. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
20. Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.
Jean J; Kovach AE; Doan A; Oberley M; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
Blood Adv; 2022 Jun; 6(11):3343-3346. PubMed ID: 35245931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
